1
Biodegradable Piezoelectric Ultrasonic Transducer Department of Mechanical Engineering, University of Connecticut Thinh T. Le and Thanh D. Nguyen INTRODUCTION - The blood brain barrier (BBB), which prevents most therapeutics from accessing the brain tissue, is the major hurdle for the treatment of brain diseases. - Ultrasound (US) has been shown to be an effective tool to disrupt the BBB. However, external focused ultrasound system is complicated and tedious, while current implanted ultrasound transducers rely on non-degradable, toxic materials. - Poly-L-lactic acid (PLLA), a biocompatible and biodegradable polymer, has been reported to exhibit the piezoelectricity when appropriately processed. - This research presents a strategy to fabricate a biodegradable piezoelectric ultrasonic transducer to facilitate the BBB opening for the delivery of drugs into the brain. MATERIALS AND DEVICE DESIGN - The electrospun PLLA nanofibers were collected on a very high spin speeds collector drum (4000 rpm). The PLLA fiber mats was processed to exhibit piezoelectricity. - Molybdenum (Mo) electrodes. - Compression-molded PLA encapsulating layers. Figure 1. Biodegradable piezoelectric PLLA ultrasonic transducer. a. Optical image of the ultrasonic transducer ( scale bar 3 mm). b. Simplified schematic depicting the structure of PLLA device. DEVICE CHARACTERIZATION BLOOD - BRAIN BARRIER DISRUPTION Spatial Pressure Field Figure 2. Spatial pressure field of the 5 x 5 mm biodegradable transducers in DI water at 1 MHz. The pressure shown was normalized to the acoustic pressure at the point (0,8,0), indicated by “x” in the graph. a. The spatial field mapping was performed on the transverse plane and longitudinal plane of the biodegradable transducer by using a hydrophone. b. Pressure field on the transverse plane. c. Pressure field on the longitudinal plane. Biodegradation and Functional Lifetime Figure 3. Biodegradability of The Piezoelectric Ultrasonic Transducer. Figure 5. In vivo experiment setup to demonstrate the ability to disrupt the BBB. On the left, the diagram of the system and positions for coronal sections relative to the sensor implantation site. On the right, optical image of the mouse head, receiving the implanted US transducer with the wound closed via medical suture. Figure 6. In vivo experiment results presenting the ability to open the BBB and facilitate drug delivery to brain tissue. a. Representative fluorescent images showing the auto-fluorescent signal of blood protein at the coronal section (C2) between experimental and control groups. b. Representative fluorescent images show the blood protein signal at different coronal sections of the same mouse brain receiving the ultrasound treatment. Scale bars are 30 μm. c. Representative images show the signal of dextran (FITC) at the coronal sections from the brains of experimental groups vs others two control groups. The dash lines show the boundary between the brain and the biodegradable device. The asterisk (*) shows the position of the implanted device. Scale bars are 50 μm. Conclusion Biocompatibility in rats Figure 4. Immuno- histochemistry staining (IHC) of brain tissue shows biocompatibility of the PLLA transducer for 4-weeks brain- implantation in rats. a. The optical images of a typical biodegradable US nanofiber transducer at different days in the buffered solution at an accelerated-degradation temperature of 70˚C (scale bars are 3 mm). b. Output pressure from the biodegradable PLLA ultrasound transducer made from piezoelectric electrospun PLLA under the same input voltage at the initial day, day 4 and day 8 in phosphate buffered saline solution at 37˚C. - We have presented design of a biodegradable implanted ultrasonic transducer which can locally and effectively disrupt the blood-brain barrier to facilitate the delivery of drugs into the brain for the treatment of various brain diseases or disorders. - The improvements of this device can profoundly impact various field of medical field. References 1. Curry, Eli J., et al. "Biodegradable piezoelectric force sensor." Proceedings of the National Academy of Sciences 115.5 (2018): 909-914. 2. Curry, Eli J., et al. "Biodegradable nanofiber-based piezoelectric transducer." Proceedings of the National Academy of Sciences 117.1 (2020): 214-220. Acknowledgement The project is in part funded by the NIH grant 1R21AR075196. The authors thank Mark Bouley and Peter Glaude for their help with the design and fabrication of the electrospinning box. We thank Dr. Laura Pinatti for assistance with DSC. We thank Sanja Novak for her help with the retro-orbital injection. We thank Lisa Chubba and Shaelyn Killoh for their assistance with the tail vein injection.

Biodegradable Piezoelectric Ultrasonic Transducer

  • Upload
    others

  • View
    11

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Biodegradable Piezoelectric Ultrasonic Transducer

Biodegradable Piezoelectric Ultrasonic Transducer

Department of Mechanical Engineering, University of Connecticut

Thinh T. Le and Thanh D. Nguyen

INTRODUCTION- The blood brain barrier (BBB), which prevents most therapeutics

from accessing the brain tissue, is the major hurdle for the treatment

of brain diseases.

- Ultrasound (US) has been shown to be an effective tool to disrupt the

BBB. However, external focused ultrasound system is complicated

and tedious, while current implanted ultrasound transducers rely on

non-degradable, toxic materials.

- Poly-L-lactic acid (PLLA), a biocompatible and biodegradable

polymer, has been reported to exhibit the piezoelectricity when

appropriately processed.

- This research presents a strategy to fabricate a biodegradable

piezoelectric ultrasonic transducer to facilitate the BBB opening for

the delivery of drugs into the brain.

MATERIALS AND DEVICE DESIGN

- The electrospun PLLA nanofibers were collected on a very high

spin speeds collector drum (4000 rpm). The PLLA fiber mats was

processed to exhibit piezoelectricity.

- Molybdenum (Mo) electrodes.

- Compression-molded PLA encapsulating layers.

Figure 1. Biodegradable piezoelectric PLLA ultrasonic transducer. a. Optical

image of the ultrasonic transducer ( scale bar 3 mm). b. Simplified schematic depicting the

structure of PLLA device.

DEVICE CHARACTERIZATION

BLOOD-BRAIN BARRIER DISRUPTION

Spatial Pressure Field

Figure 2. Spatial pressure field of the 5 x 5 mm biodegradable transducers in

DI water at 1 MHz. The pressure shown was normalized to the acoustic pressure at the point

(0,8,0), indicated by “x” in the graph. a. The spatial field mapping was performed on the transverse

plane and longitudinal plane of the biodegradable transducer by using a hydrophone. b. Pressure field

on the transverse plane. c. Pressure field on the longitudinal plane.

Biodegradation and Functional Lifetime

Figure 3. Biodegradability of The

Piezoelectric Ultrasonic Transducer.

Figure 5. In vivo experiment setup

to demonstrate the ability to disrupt

the BBB. On the left, the diagram of the

system and positions for coronal sections

relative to the sensor implantation site. On

the right, optical image of the mouse head,

receiving the implanted US transducer with

the wound closed via medical suture.

Figure 6. In vivo experiment results presenting the ability to open the BBB and

facilitate drug delivery to brain tissue. a. Representative fluorescent images showing the

auto-fluorescent signal of blood protein at the coronal section (C2) between experimental and

control groups. b. Representative fluorescent images show the blood protein signal at different

coronal sections of the same mouse brain receiving the ultrasound treatment. Scale bars are 30 µm.

c. Representative images show the signal of dextran (FITC) at the coronal sections from the brains

of experimental groups vs others two control groups. The dash lines show the boundary between the

brain and the biodegradable device. The asterisk (*) shows the position of the implanted device.

Scale bars are 50 µm.

Conclusion

Biocompatibility in rats

Figure 4. Immuno-

histochemistry

staining (IHC) of

brain tissue shows

biocompatibility of the

PLLA transducer for

4-weeks brain-

implantation in rats.

a. The optical images of a typical biodegradable

US nanofiber transducer at different days in the

buffered solution at an accelerated-degradation

temperature of 70˚C (scale bars are 3 mm). b.

Output pressure from the biodegradable PLLA

ultrasound transducer made from piezoelectric

electrospun PLLA under the same input voltage at

the initial day, day 4 and day 8 in phosphate

buffered saline solution at 37˚C.

- We have presented design of a biodegradable implanted ultrasonic

transducer which can locally and effectively disrupt the blood-brain

barrier to facilitate the delivery of drugs into the brain for the

treatment of various brain diseases or disorders.

- The improvements of this device can profoundly impact various field

of medical field.

References1. Curry, Eli J., et al. "Biodegradable piezoelectric force sensor." Proceedings of the National Academy of

Sciences 115.5 (2018): 909-914.

2. Curry, Eli J., et al. "Biodegradable nanofiber-based piezoelectric transducer." Proceedings of the National

Academy of Sciences 117.1 (2020): 214-220.

AcknowledgementThe project is in part funded by the NIH grant 1R21AR075196. The authors thank Mark Bouley and Peter

Glaude for their help with the design and fabrication of the electrospinning box. We thank Dr. Laura Pinatti

for assistance with DSC. We thank Sanja Novak for her help with the retro-orbital injection. We thank Lisa

Chubba and Shaelyn Killoh for their assistance with the tail vein injection.